Filing Flows › CareDx (CDNA) › Q2 2026 › vs Q1 2026
CareDx (CDNA) Q2 2026 vs Q1 2026 (quarter over quarter)
CareDx's revenue rose $14.2M (+12%) from $118M in Q1 2026 to $132M in Q2 2026. The biggest changes: Testing services revenue +$8.5M (+9%); Patient and digital solutions revenue +$3.3M (+21%); Product revenue +$2.4M (+24%). Operating margin 85.8% against 1.0% (+84.8 pts).
CareDx, Q2 2026: revenue $132M (+52% year over year), operating margin 85.8%, net earnings $111M, operating cash flow $30.6M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 85.8% | 1.0% | +84.8 pts |
| Net margin | 83.8% | 2.4% | +81.5 pts |
| Free cash flow margin | 21.8% | 0.4% | +21.3 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Testing services revenue | $99.9M | $91.4M | $8.5M | +9% |
| Patient and digital solutions revenue | $19.2M | $16.0M | $3.3M | +21% |
| Product revenue | $12.8M | $10.3M | $2.4M | +24% |
| Revenue | $132M | $118M | $14.2M | +12% |
| Other income, net | $1.3M | $1.6M | −$284K | -18% |
| Operating profit | $113M | $1.2M | $112M | 95× |
| Costs & expenses | $18.7M | $117M | −$97.8M | -84% |
| Pre-tax earnings | $115M | $2.8M | $112M | 41× |
| Net earnings | $111M | $2.8M | $108M | 39× |
| Income tax | $3.9M | −$32K | $3.9M | — |
| Depreciation & amortization | $2.8M | $3.9M | −$1.1M | -28% |
| Share-based compensation | $10.7M | $9.8M | $851K | +9% |
| Working capital & other | $93.5M | $12.2M | $81.3M | +668% |
| Operating cash flow | $30.6M | $4.3M | $26.3M | +606% |
| Free cash flow (OCF − capex) | $28.7M | $514K | $28.2M | 56× |
| Capital expenditures | $1.9M | $3.8M | −$2.0M | -51% |
Questions
How much did CareDx's revenue grow quarter over quarter in Q2 2026?
CareDx's revenue rose $14.2M (+12%) from $118M in Q1 2026 to $132M in Q2 2026.
What drove CareDx's revenue change in Q2 2026?
Testing services revenue +$8.5M (+9%); Patient and digital solutions revenue +$3.3M (+21%); Product revenue +$2.4M (+24%).